Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Pharmacy staff profile

Dr Anita Barzegar Fallah

PositionResearch Assistant
QualificationsPharmD PhD
Research summaryMolecular and cellular neuroscience, angiogenesis and tumor progression.

Publications

Barzegar-Fallah, N., Baery, N., Soleymankhani, M., Malekmohammadi, N., Alimoradi, H., Parsa, A., & Barzegar-Fallah, A. (2016). Kelussia odoratissima Mozaff attenuates thromboembolic brain injury, possibly due to its Z-ligustilide content. Brain Injury, 30(7), 926-932. doi: 10.3109/02699052.2016.1144083

Barzegar-Fallah, A., Alimoradi, H., Razmi, A., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy. European Journal of Pharmacology, 767, 152-159. doi: 10.1016/j.ejphar.2015.10.019

Barzegar-Fallah, A., Alimoradi, H., Asadi, F., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Clinical & Experimental Pharmacology & Physiology, 42(4), 361-368. doi: 10.1111/1440-1681.12373

Journal - Research Article

Barzegar-Fallah, N., Baery, N., Soleymankhani, M., Malekmohammadi, N., Alimoradi, H., Parsa, A., & Barzegar-Fallah, A. (2016). Kelussia odoratissima Mozaff attenuates thromboembolic brain injury, possibly due to its Z-ligustilide content. Brain Injury, 30(7), 926-932. doi: 10.3109/02699052.2016.1144083

Barzegar-Fallah, A., Alimoradi, H., Razmi, A., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy. European Journal of Pharmacology, 767, 152-159. doi: 10.1016/j.ejphar.2015.10.019

Barzegar-Fallah, A., Alimoradi, H., Asadi, F., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Clinical & Experimental Pharmacology & Physiology, 42(4), 361-368. doi: 10.1111/1440-1681.12373

More publications...